Spectral AI, Inc. Warrants
MDAIW
About: Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
Employees: 78
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
167% more capital invested
Capital invested by funds: $600K [Q1] → $1.6M (+$1M) [Q2]
7.48% more ownership
Funds ownership: 6.85% [Q1] → 14.32% (+7.48%) [Q2]
5% less funds holding
Funds holding: 19 [Q1] → 18 (-1) [Q2]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Financial journalist opinion
We haven’t received any recent news articles for MDAIW